Investigating how CARM1 affects Acute Myeloid Leukemia
Dependency of AML on CARM1 activity
This study is looking at how a specific enzyme called CARM1 affects Acute Myeloid Leukemia (AML) and hopes to find a way to stop AML cells from growing while keeping healthy blood cells safe, which could help many people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-10912450 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the enzyme CARM1 in Acute Myeloid Leukemia (AML). It aims to explore how inhibiting CARM1 can lead to the differentiation and death of AML cells while sparing normal blood stem cells. By using advanced techniques like mass-spectrometry and RNA sequencing, the study seeks to identify the molecular mechanisms behind CARM1's effects on AML. This approach represents a shift from targeting specific mutations to targeting broader regulatory mechanisms that could benefit many AML patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with Acute Myeloid Leukemia who may benefit from novel therapeutic strategies.
Not a fit: Patients with other types of leukemia or those whose AML is not dependent on CARM1 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively treat a significant number of AML patients by targeting CARM1.
How similar studies have performed: Other research has shown promising results in targeting chromatin modifiers in cancer treatment, suggesting potential success for this novel approach.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Nimer, Stephen D. — University of Miami School of Medicine
- Study coordinator: Nimer, Stephen D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.